Christopher J Joyce Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 4 months ago
Christopher J Joyce has an estimated net worth of at least $10.4 million*, as of April 16, 2025. They own 374,531 shares of ALHC stock. They have sold 334,104 shares of ALHC stock since 2021, for an estimated $2.2 million.
Christopher J Joyce $ALHC SEC Form 4 Insider Trading
Christopher J Joyce has filed a total of 21 insider trades in $ALHC since 2021. Their most recent trade was a sale of 15,491 shares, made on Jul 31, 2025. Their largest trade was a sale of 25,060 shares, made on Mar 19, 2024. We estimate that they now own 374,531 shares of $ALHC, worth an estimated $8.2 million.
Insider Trading at $ALHC
There have been a total of 285 insider trades reported at $ALHC since 2021, with 203,000 shares purchased and 86.7 million shares sold. The most active insider traders in $ALHC stock have been Robert Thomas Freeman, John E Kao, and Dawn Christine Maroney. The most recent trade was a sale of 18,600 shares reported by Hyong Kim (Chief Medical Officer), made on Aug 13, 2025.
History of Insider Stock Trades by Christopher J Joyce
| Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
|---|---|---|---|---|
ALHC
|
Sale | 15,491 | Jul 31, 2025 | Aug. 1, 2025, 6:28 p.m. |
|
ALHC
|
Sale | 25,000 | May 01, 2025 | May 2, 2025, 4:29 p.m. |
|
ALHC
|
Sale | 25,000 | Apr 01, 2025 | April 2, 2025, 7:05 p.m. |
|
ALHC
|
Sale | 6,725 | Mar 18, 2025 | March 19, 2025, 9:52 p.m. |
|
ALHC
|
Sale | 7,057 | Mar 19, 2025 | March 19, 2025, 9:52 p.m. |
|
ALHC
|
Sale | 3,959 | Mar 19, 2025 | March 19, 2025, 9:52 p.m. |
|
ALHC
|
Sale | 25,000 | Mar 04, 2025 | March 6, 2025, 8:25 p.m. |
|
ALHC
|
Sale | 10,871 | Mar 06, 2025 | March 6, 2025, 8:25 p.m. |
|
ALHC
|
Sale | 667 | Oct 01, 2024 | Oct. 3, 2024, 6:19 p.m. |
|
ALHC
|
Sale | 10,159 | Sep 11, 2024 | Sept. 13, 2024, 6:22 p.m. |
|
ALHC
|
Sale | 24,467 | Sep 11, 2024 | Sept. 13, 2024, 6:22 p.m. |
|
ALHC
|
Sale | 4,541 | Sep 05, 2024 | Sept. 6, 2024, 5:29 p.m. |
|
ALHC
|
Sale | 1,300 | Sep 04, 2024 | Sept. 6, 2024, 5:29 p.m. |
|
ALHC
|
Sale | 1,233 | Aug 02, 2024 | Aug. 6, 2024, 6:13 p.m. |
|
ALHC
|
Sale | 100 | Aug 02, 2024 | Aug. 6, 2024, 6:13 p.m. |
|
ALHC
|
Sale | 300 | Jul 12, 2024 | July 16, 2024, 4:30 p.m. |
|
ALHC
|
Sale | 15,034 | Jul 15, 2024 | July 16, 2024, 4:30 p.m. |
|
ALHC
|
Sale | 666 | Jul 01, 2024 | July 3, 2024, 5:37 p.m. |
|
ALHC
|
Sale | 16,000 | Jun 14, 2024 | June 17, 2024, 8:29 p.m. |
|
ALHC
|
Sale | 25,060 | Mar 19, 2024 | March 21, 2024, 5 p.m. |
|
ALHC
|
Sale | 15,474 | Sep 13, 2023 | Sept. 15, 2023, 5 p.m. |
AHCO
|
Sale | 100,000 | Aug 16, 2022 | Aug. 23, 2022, 5:55 p.m. |
$ALHC Executives and Stock Owners with Insider Trades
-
Robert Thomas Freeman, Chief Financial Officer
-
John E Kao, Chief Executive Officer
-
Dawn Christine Maroney, President, Markets
-
Christopher J Joyce, Chief Legal and Admin. Officer
-
Dinesh M. Kumar, Chief Med & Operating Officer
-
Hakan Kardes, Chief Experience Officer
-
Dawn Christine Maroney, President
-
Hyong Kim, Chief Medical Officer
-
Robert L. Scavo, Chief Information Officer
-
Andreas P. Wagner, Chief Human Resources Officer
-
Dinesh M. Kumar, Chief Medical Officer
-
Joseph S Konowiecki, Chairman of the Board
-
Richard A. Cross, SVP, General Counsel
-
Sebastian Burzacchi, COO - Mgmt Services Org
-
Donald Steven Furman, Chief Clinical Officer
-
Rajesh Shrestha, Pres., New Markets & CBO
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.